Literature DB >> 12064893

Long-term consequences of childhood-onset congenital adrenal hyperplasia.

Perrin C White1, Phyllis W Speiser.   

Abstract

Congenital adrenal hyperplasia (CAH) is a general term applied to several diseases caused by inherited defects of cortisol synthesis. The most common of these is steroid 21-mono-oxygenase (also termed 21-hydroxylase) deficiency (CAH-21OHD), found in approximately 1:10 000-1:15 000 live births. Potentially lethal adrenal insufficiency is characteristic of about two-thirds to three-quarters of patients with the classic salt-wasting form of CAH-21OHD. Non-salt-wasting forms of CAH-21OHD may be diagnosed based in part on genital ambiguity in affected newborn females, and/or by later evidence of androgen excess in members of either sex. Non-classical CAH-21OHD may be detected in up to 1-3% of certain populations, and is often mistaken for idiopathic precocious pubarche in children or polycystic ovary syndrome in young women. This chapter addresses issues relating to long-term consequences in adult life of CAH-21OHD diagnosed in early childhood or adolescence. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064893     DOI: 10.1053/beem.2002.0198

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  5 in total

Review 1.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 2.  Congenital adrenal hyperplasia in pregnancy: approach depends on who is the 'patient'.

Authors:  Erin Keely; Janine Malcolm
Journal:  Obstet Med       Date:  2012-09-24

3.  No evidence for a difference in 2D:4D ratio between youth with elevated prenatal androgen exposure due to congenital adrenal hyperplasia and controls.

Authors:  Gideon Nave; Christina M Koppin; Dylan Manfredi; Gareth Richards; Steven J Watson; Mitchell E Geffner; Jillian E Yong; Robert Kim; Heather M Ross; Monica Serrano-Gonzalez; Mimi S Kim
Journal:  Horm Behav       Date:  2020-12-09       Impact factor: 3.587

Review 4.  Management issues of congenital adrenal hyperplasia during the transition from pediatric to adult care.

Authors:  Jin-Ho Choi; Han-Wook Yoo
Journal:  Korean J Pediatr       Date:  2017-02-27

Review 5.  Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency.

Authors:  Mouna Feki Mnif; Mahdi Kamoun; Faten Hadj Kacem; Fatma Mnif; Nadia Charfi; Basma Ben Naceur; Nabila Rekik; Mohamed Abid
Journal:  Indian J Endocrinol Metab       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.